Vitro Biotechnologies Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.14 Cr
- Company Age 35 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.45 Cr
- Revenue Growth 78.82%
- Profit Growth 1986.77%
- Ebitda -71.10%
- Net Worth 4.11%
- Total Assets -19.99%
About Vitro Biotechnologies
Vitro Biotechnologies Limited (VBL) is a Public Limited Indian Non-Government Company incorporated in India on 22 September 1989 and has a history of 35 years and five months. Its registered office is in New Delhi, Delhi, India.
The Corporate was formerly known as Sheel Greens Nature Care Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.14 Cr.
The company has closed loans amounting to ₹3.45 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Bharat Sharma, Himanshu Manwani, and Amit Sehgal serve as directors at the Company.
Company Details
- Location
New Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74899DL1989PLC037779
- Company No.
037779
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Sep 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Vitro Biotechnologies?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharat Sharma  | Additional Director | 10-May-2024 | Current |
| Himanshu Manwani | Director | 20-Dec-2021 | Current |
| Amit Sehgal | Director | 01-Jan-2020 | Current |
Financial Performance of Vitro Biotechnologies.
Vitro Biotechnologies Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 78.82% increase. The company also saw a substantial improvement in profitability, with a 1986.77% increase in profit. The company's net worth moved up by a moderate rise of 4.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vitro Biotechnologies?
In 2023, Vitro Biotechnologies had a promoter holding of 71.72% and a public holding of 28.28%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹3.45 Cr
Charges Breakdown by Lending Institutions
- Canara Bank : 3.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Dec 1993 | Canara Bank | ₹3.45 Cr | Satisfied |
How Many Employees Work at Vitro Biotechnologies?
Unlock and access historical data on people associated with Vitro Biotechnologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vitro Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vitro Biotechnologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
